Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-03-02 @ 3:59 PM
Study NCT ID:
NCT04083833
Status:
COMPLETED
Last Update Posted:
2019-09-10
First Post:
2019-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects
Sponsor:
Wex Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-06
First Submit QC Date:
None
Study First Post Date:
2019-09-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-06
Last Update Post Date:
2019-09-10
Last Update Post Date Type:
ACTUAL